Pilocarpine 1.25% efficacy for management of uncorrected presbyopia (PILE-UP study)
Pilocarpine 1.25% eye drops demonstrated statistically significant improvements in DCNVA, near add, AoA, and DoF after one month of treatment. Pilocarpine 1.25% eye drops shown increase in the AoA and DoF; without any significant change in ocular biometry parameters. The use of pilocarpine 1.25% eye drops can be an alternative intervention for enhancing near vision acuity of presbyopic subjects.
Authors
- Thirumurthy Velpandian (ORCID: https://orcid.org/0000-0003-0334-5197)
- Himani Thakur (ORCID: https://orcid.org/0009-0003-3602-7459)
- Rohit Saxena (ORCID: https://orcid.org/0000-0002-8660-8062)
- Vinay Gupta (ORCID: https://orcid.org/0000-0002-6139-4950)
- Namrata Sharma (ORCID: https://orcid.org/0000-0002-2124-7542)
- Tanya Nidhi
- JeewanS Titiyal
Institutions
- All India Institute of Medical Sciences Raipur (IN)
- All India Institute of Medical Sciences Bhopal (IN)
- All India Institute of Medical Sciences (IN)
Publication Details
- Journal
- Indian Journal of Ophthalmology
- Published
- 2025-09-25
- DOI
- https://doi.org/10.4103/ijo.ijo_96_25
- Primary Topic
- Ophthalmology and Visual Impairment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00